PLK1 and familial pancreatic carcinoma: One approach involves using superparamagnetic iron oxide nanoparticles coupled with PLK1-siRNA to specifically inhibit PLK1 expression and suppress pancreatic cancer cell proliferation (Mahajan et al., 2016).